Capsazepine |
| Catalog No.GC17918 |
Capsazepine is a specific antagonist of the transient receptor potential vanilloid 1 (TRPV1) receptor with an IC50 value of 562nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 138977-28-3
Sample solution is provided at 25 µL, 10mM.
Capsazepine is a specific antagonist of the transient receptor potential vanilloid 1 (TRPV1) receptor with an IC50 value of 562nM [1]. Capsazepine is a synthetic analogue of capsaicin, which is the primary pungent component found in chili peppers[2]. TRPV1 is a non-selective cation channel that participates in various physiological and pathological processes such as pain perception, temperature regulation, and inflammatory response[3]. Capsazepine serves as a therapeutic agent for pain management by acting through TRPV1. Capsazepine also exhibits anticancer and anti-inflammatory effects, making it widely used in the treatment of various diseases, including pancreatic cancer, breast cancer, pancreatitis, and neurogenic inflammation[4].
In vitro, capsazepine(0-60μM) treated human DU145 prostate cancer cells for 24h experience suppressed proliferation and enhanced apoptosis. Following a 6-hour exposure to the 1, 2.5, 5μM of capsazepine, DU145 cells demonstrated inhibition of JAK phosphorylation and STAT activation[5]. Capsazepin(0-200μM) concentration dependently triggers an immediate rise of intracellular [Ca2+] and exhibits a cytotoxic effect after 5h treatment in PC-3 prostate cells[6]. Capsazepine can also lead to a substantial programmed cell death in MDA-MB-231 cells within 48h at concentrations exceeding 25μM, and colorectal HCT116 cells at 10 or 30μM or 6h by increased ROS production[4].
In vivo, intraperitoneal injection of capsazepine at doses of 1mg/kg and 5mg/kg, 3 times/week inhibits disease progression in prostate cancer xenograft mice by reducing constitutive p-STAT3 expression and increasing PTPε protein levels in tumor tissue, comparing to the control group receiving PBS treatment[5]. Subcutaneous administration of capsazepine (3–10mg/kg) in osteosarcoma bearing mice 1h before tests can inhibit cancer hyperalgesia in a dose-dependant manner[7]. Pretreated with capsazepine at a dose of 100μmol/kg via subcutaneous injection miligate pancreatic inflammation in male Sprague-Dawley rats as the therapeutic efficacy is evaluated by pancreatic edema, myeloperoxidase (MPO) activity and histological grading [8].
References:
[1] Seabrook, G.R.,Sutton,K.G., Jarolimek,W et al. Functional Properties of the High-Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist (4- Hydrox -5-iodo-3 -methoxyphenylacetate ester)Iodo-Resiniferatoxin. Journal of Pharmacology and Experimental Therapeutics. 2002.303(3), 1052–1060.
[2] Bevan S.,Hothi S.,Hughes G., et al.Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol. 1992 Oct;107(2):544-52.
[3] Tabrizi, A.M, Baraldi,G.P.,Baraldi S., et al.Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists. Med Res Rev. 2017 Jul;37(4):936-983.
[4] Yang, M.H, Jung S.H., Gautam Sethi G., Ahn K.S.,Pleiotropic Pharmacological Actions of Capsazepine, a Synthetic Analogue of Capsaicin, against Various Cancers and Inflammatory Diseases. Molecules. 2019 Mar 12;24(5):995.
[5] Lee J.H., Kim C., Baek S.H., et al. Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer. Oncotarget. 2017;8:17700–17711.
[6] Huang J.K., Cheng H.H., Huang C.J., et al. Effect of capsazepine on cytosolic Ca(2+) levels and proliferation of human prostate cancer cells. Toxicology In Vitro. 2006;20:567–574.
[7] Menéndez L., Juárez L., García E , García-Suárez O, et al.Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice.Neurosci Lett. 2006 Jan 23;393(1):70-3.
[8] Vigna S.R., Shahid R.A., Nathan J.D., McVey D.C., Liddle R.A. Leukotriene B4 mediates inflammation via TRPV1 in duct obstruction-induced pancreatitis in rats. Pancreas. 2011;40:708–714.
| Cell experiment [1]: | |
Cell lines | Human PC-3 prostate cancer cells |
Preparation Method | PC-3 Cells were seeded in 96-well plates at a density of 10,000 cells per well in culture medium for 16h to allow attachment. On the next day, the culture medium was replaced with 100μl of serum-free medium containing 0–200μM capsazepine. |
Reaction Conditions | 200μM; 5h |
Applications | Capsazepine inhibits prostate cancer cell proliferation and induce apoptosis by evoking the intercellular Ca2+ concentration rise. |
| Animal experiment [2]: | |
Animal models | Six-week-old athymic balb/c nu/nu male mice |
Preparation Method | DU145 cells (1× 107 cells/mice) were injected subcutaneously into the right flanks of the mice. The animals were randomized into three groups 1 week after tumor cell injection based on tumor volume. Group I (control) was treated with PBS (100μL i.p. 3 times/week), group II with capsazepine (1mg/kg i.p. 3times/week), and group III with capsazepine (5mg/kg i.p. 3 times/week). Treatment began 1 week after implantation and continued for up to 20 days. Tumor diameters were measured every 5 days. |
Dosage form | 1 and 5mg/kg; i.p.; 3 times/week |
Applications | Capsazepine dose-dependantly inhibits tumor growth in xenograft prostate cancer model by reducing constitutive p-STAT3 expression and increasing PTPε protein levels |
References: | |
| Cas No. | 138977-28-3 | SDF | |
| Chemical Name | N-[2-(4-chlorophenyl)ethyl]-7,8-dihydroxy-1,3,4,5-tetrahydro-2-benzazepine-2-carbothioamide | ||
| Canonical SMILES | C1CC2=CC(=C(C=C2CN(C1)C(=S)NCCC3=CC=C(C=C3)Cl)O)O | ||
| Formula | C19H21ClN2O2S | M.Wt | 376.9 |
| Solubility | ≥ 22 mg/mL in DMSO with gentle warming, ≥ 18.85 mg/mL in EtOH with gentle warming | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.6532 mL | 13.2661 mL | 26.5322 mL |
| 5 mM | 0.5306 mL | 2.6532 mL | 5.3064 mL |
| 10 mM | 0.2653 mL | 1.3266 mL | 2.6532 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *